Terephthalic Acid

Terephthalic Acid

SCHEMBL9872879

CC1(C)CC(C)(C)c2cc(S)ccc2O1.O=C(O)c1ccc(C(=O)O)cc1

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1

The experimentally established mechanism targets of Terephthalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SSTR5 P35346 1/20 0.49
AKR1B1 P15121 3/20 0.45
RARB P10826 8/20 0.43
RARG P13631 8/20 0.43
RARA P10276 7/20 0.43
RXRA P19793 8/20 0.41
RXRB P28702 7/20 0.40
RXRG P48443 6/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPK1 P28482 1/20 0.40
SRD5A2 P31213 1/20 0.39
CYP26A1 O43174 1/20 0.38
CYP3A4 P08684 1/20 0.38
CRABP2 P29373 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isophthalic Acid SCHEMBL9870177 0.91 AKR1B1 (0.43) SSTR5AKR1B1RARBRARGRARA
SCHEMBL5736575 0.88 SSTR5 (0.50) SSTR5AKR1B1RARBRARGRARA
SCHEMBL27259756 0.88 AKR1B1 (0.43) SSTR5AKR1B1ALDH1A1CYP26A1
SCHEMBL9180357 0.83 RARB (0.60) SSTR5RARBRARGRARACYP26A1
SCHEMBL8758787 0.82 RARB (0.46) SSTR5AKR1B1RARBRARGRARA
SCHEMBL9850145 0.81 SSTR5 (0.46) SSTR5RARBRARGRARARXRA
SCHEMBL8158757 0.81 RARA (0.62) SSTR5RARBRARGRARAALDH1A1
SCHEMBL9076001 0.80 RARB (0.71) RARBRARGRARARXRARXRB
SCHEMBL9076004 0.80 RARB (0.71) RARBRARGRARARXRARXRB
SCHEMBL9076000 0.80 RARB (0.71) RARBRARGRARARXRARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5015658-A Treatment of skin disorders such as psoriasis ALLERGAN, INC. (US) 1991-05-14 US disclosed
CN-1042147-A Have active thiochroman phenolic ester of similar retinoid and terephthalate ALLERGAN INC (US) 1990-05-16 CN disclosed